Reports for TEVA-GABAPENTIN

Brand name
TEVA-GABAPENTIN

Company Name

TEVA CANADA LIMITED

Drug Identification Number

02244515

Ingredients & Strength

Anatomical Therapeutical Chemical (ATC) Code

  • N02BF

Anatomical Therapeutical Chemical (ATC) Descriptor

Status

MARKETED
Shortage reports
Brand name Packaging size Status Date Created Date Updated Reports
TEVA-GABAPENTIN 500 Resolved 2020-10-01 2020-10-30 125494
TEVA-GABAPENTIN 100 Resolved 2023-01-19 2023-04-28 181617
TEVA-GABAPENTIN 500 Resolved 2023-02-09 2023-04-28 184189
TEVA-GABAPENTIN 500 Resolved 2024-08-08 2024-09-12 234879
TEVA-GABAPENTIN 500 Resolved 2025-08-29 2025-09-04 266184
TEVA-GABAPENTIN 100 & 500 Resolved 2025-10-10 2025-12-05 269232
TEVA-GABAPENTIN 100 & 500 Anticipated shortage 2026-02-23 2026-02-23 278689

Showing 1 to 7 of 7

Discontinuation reports
Brand name Packaging size Status Date Created Date Updated Reports

Showing 1 to 0 of 0